• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

18F-FDOPA-PET/MRI 图像融合对胃肠道神经内分泌肿瘤患者肝转移的检测影响。

The impact of 18F-FDOPA-PET/MRI image fusion in detecting liver metastasis in patients with neuroendocrine tumors of the gastrointestinal tract.

机构信息

Institute of Radiology and Nuclear Medicine, Hanusch-Hospital, Heinrich-Collin-Strasse 30, A-1140, Vienna, Austria.

Department of Nuclear Medicine with PET-Center, Wilhelminen-Hospital, Vienna, Austria.

出版信息

BMC Med Imaging. 2020 Feb 24;20(1):22. doi: 10.1186/s12880-020-00424-z.

DOI:10.1186/s12880-020-00424-z
PMID:32093632
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7038547/
Abstract

BACKGROUND

This study assesses the value of image fusion using 18F-fluoro-L-DOPA (18F-DOPA) positron emission tomography (PET) and magnetic resonance imaging (MRI) for examining patients with neuroendocrine tumors (NETs) and a suspicion of metastasis of the liver.

METHODS

Eleven patients (five women and six men aged between 20 and 81, with a mean age of 54.6 years) were included in the study. All patients underwent whole-body 18F-DOPA PET examinations and contrast-enhanced MRI with diffusion-weighted sequences (DWS). Image fusion was performed using a semiautomatic voxel-based algorithm. Images obtained using PET and MRI were assessed separately. Side-by-side evaluations of fused PET/MRI images were also performed.

RESULTS

In total, 55 liver lesions (52 liver metastases and 3 benign lesions) were detected in the 11 patients. Sensitivity detection for liver lesions was higher when using PET/CT than when using contrast-enhanced MRI without DWSs and lower than using MRI with DWSs. The sensitivity of PET/MRI image fusion in the detection of liver metastasis was significantly higher than that of MRI with DWSs (P < 0.05).

CONCLUSION

Images of the liver obtained using PET and MRI in patients with NETs exhibited characteristic features. These findings suggest that an appropriate combination of available imaging modalities can optimize patient evaluations.

摘要

背景

本研究评估了使用 18F-氟-L-多巴(18F-DOPA)正电子发射断层扫描(PET)和磁共振成像(MRI)进行神经内分泌肿瘤(NETs)患者和肝脏转移可疑患者检查的图像融合的价值。

方法

研究纳入了 11 名患者(5 名女性和 6 名男性,年龄在 20 至 81 岁之间,平均年龄为 54.6 岁)。所有患者均接受了全身 18F-DOPA PET 检查和增强 MRI 检查,包括弥散加权序列(DWS)。图像融合使用半自动体素基算法完成。分别评估 PET 和 MRI 获得的图像。还对融合的 PET/MRI 图像进行并排评估。

结果

在 11 名患者中,共发现 55 个肝脏病变(52 个肝转移和 3 个良性病变)。与未行 DWS 的增强 MRI 相比,PET/CT 对肝脏病变的检测敏感性更高,而低于 DWS 的 MRI。PET/MRI 图像融合检测肝转移的敏感性明显高于 DWS 的 MRI(P<0.05)。

结论

NETs 患者的 PET 和 MRI 肝脏图像具有特征性表现。这些发现表明,适当结合现有成像方式可以优化患者评估。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4fc3/7038547/3c104f9e5ce7/12880_2020_424_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4fc3/7038547/cbf4a2dc2e09/12880_2020_424_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4fc3/7038547/3c104f9e5ce7/12880_2020_424_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4fc3/7038547/cbf4a2dc2e09/12880_2020_424_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4fc3/7038547/3c104f9e5ce7/12880_2020_424_Fig2_HTML.jpg

相似文献

1
The impact of 18F-FDOPA-PET/MRI image fusion in detecting liver metastasis in patients with neuroendocrine tumors of the gastrointestinal tract.18F-FDOPA-PET/MRI 图像融合对胃肠道神经内分泌肿瘤患者肝转移的检测影响。
BMC Med Imaging. 2020 Feb 24;20(1):22. doi: 10.1186/s12880-020-00424-z.
2
Simultaneous 68Ga-DOTATOC PET/MRI in patients with gastroenteropancreatic neuroendocrine tumors: initial results.68Ga-DOTATOC PET/MRI 同机融合显像在胃肠胰神经内分泌肿瘤中的初步应用
Invest Radiol. 2013 May;48(5):273-9. doi: 10.1097/RLI.0b013e3182871a7f.
3
Whole-body MRI including diffusion-weighted MRI compared with 5-HTP PET/CT in the detection of neuroendocrine tumors.全身磁共振成像(包括弥散加权磁共振成像)与5-羟色氨酸正电子发射断层扫描/计算机断层扫描(5-HTP PET/CT)在神经内分泌肿瘤检测中的比较。
Ups J Med Sci. 2017 Mar;122(1):43-50. doi: 10.1080/03009734.2016.1248803. Epub 2016 Nov 29.
4
The Added Diagnostic Value of F-Fluorodihydroxyphenylalanine PET/CT in the Preoperative Work-Up of Small Bowel Neuroendocrine Tumors.F-氟代二羟苯丙氨酸 PET/CT 对小肠神经内分泌肿瘤术前评估的附加诊断价值。
J Gastrointest Surg. 2018 Apr;22(4):722-730. doi: 10.1007/s11605-017-3645-1. Epub 2017 Dec 12.
5
The added diagnostic value of complementary gadoxetic acid-enhanced MRI to F-DOPA-PET/CT for liver staging in medullary thyroid carcinoma.钆塞酸增强 MRI 对 F-DOPA-PET/CT 用于甲状腺髓样癌肝脏分期的附加诊断价值。
Cancer Imaging. 2019 Nov 14;19(1):73. doi: 10.1186/s40644-019-0263-z.
6
Imaging of advanced neuroendocrine tumors with (18)F-FDOPA PET.采用(18)F - FDOPA PET对晚期神经内分泌肿瘤进行成像。
J Nucl Med. 2004 Jul;45(7):1161-7.
7
Gadoxetate-enhanced versus diffusion-weighted MRI for fused Ga-68-DOTANOC PET/MRI in patients with neuroendocrine tumours of the upper abdomen.镓-68-DOTANOC PET/MRI 融合显像中增强型钆塞酸二钠对比弥散加权成像在评价上腹部神经内分泌肿瘤中的应用
Eur Radiol. 2013 Jul;23(7):1978-85. doi: 10.1007/s00330-013-2785-2. Epub 2013 Mar 8.
8
Role of 18F-dopa PET/CT imaging in the management of patients with 111In-pentetreotide negative GEP tumours.18F-多巴PET/CT成像在111In-喷曲肽阴性胃肠胰肿瘤患者管理中的作用
Nucl Med Commun. 2007 Jun;28(6):473-7. doi: 10.1097/MNM.0b013e328182d606.
9
Integrated whole-body PET/MRI with 18F-FDG, 18F-FDOPA, and 18F-FDA in paragangliomas in comparison with PET/CT: NIH first clinical experience with a single-injection, dual-modality imaging protocol.18F-FDG、18F-FDOPA 和 18F-FDA 联合全身 PET/MRI 与 PET/CT 在副神经节瘤中的对比:NIH 应用单次注射、双模式成像方案的首项临床经验。
Clin Nucl Med. 2014 Mar;39(3):243-50. doi: 10.1097/RLU.0000000000000289.
10
Value of retrospective fusion of PET and MR images in detection of hepatic metastases: comparison with 18F-FDG PET/CT and Gd-EOB-DTPA-enhanced MRI.回顾性融合 PET 和 MR 图像在肝转移检测中的价值:与 18F-FDG PET/CT 和 Gd-EOB-DTPA 增强 MRI 的比较。
J Nucl Med. 2010 May;51(5):692-9. doi: 10.2967/jnumed.109.068510. Epub 2010 Apr 15.

引用本文的文献

1
PET/MRI: pictorial review of hepatobiliary and pancreatic applications.PET/MRI:肝胆胰应用的影像学综述
Abdom Radiol (NY). 2025 Feb;50(2):875-901. doi: 10.1007/s00261-024-04548-6. Epub 2024 Sep 10.
2
PET/MRI imaging in neuroendocrine neoplasm.正电子发射断层扫描/磁共振成像在神经内分泌肿瘤中的应用。
Abdom Radiol (NY). 2023 Dec;48(12):3585-3600. doi: 10.1007/s00261-022-03757-1. Epub 2022 Dec 16.
3
F FDG PET/MRI with hepatocyte-specific contrast agent for M staging of rectal cancer: a primary economic evaluation.使用肝细胞特异性对比剂的 F-FDG PET/MRI 对直肠癌 M 分期的初步经济评估。

本文引用的文献

1
Role of Combined [Ga]Ga-DOTA-SST Analogues and [F]FDG PET/CT in the Management of GEP-NENs: A Systematic Review.联合使用[镓]镓-多柔比星生长抑素类似物和[氟]氟代脱氧葡萄糖PET/CT在胃肠胰神经内分泌肿瘤管理中的作用:一项系统评价
J Clin Med. 2019 Jul 13;8(7):1032. doi: 10.3390/jcm8071032.
2
Iodine quantification to distinguish hepatic neuroendocrine tumor metastasis from hepatocellular carcinoma at dual-source dual-energy liver CT.双源双能 CT 碘定量鉴别肝脏神经内分泌肿瘤转移与肝细胞癌。
Eur J Radiol. 2018 Aug;105:20-24. doi: 10.1016/j.ejrad.2018.05.019. Epub 2018 May 19.
3
Imaging features of malignant abdominal neuroendocrine tumors with rare presentation.
Eur J Nucl Med Mol Imaging. 2021 Sep;48(10):3268-3276. doi: 10.1007/s00259-021-05193-7. Epub 2021 Mar 9.
表现罕见的恶性腹部神经内分泌肿瘤的影像学特征
Clin Imaging. 2018 Sep-Oct;51:59-64. doi: 10.1016/j.clinimag.2018.02.004. Epub 2018 Feb 8.
4
The utility of Ga-DOTATATE positron-emission tomography/computed tomography in the diagnosis, management, follow-up and prognosis of neuroendocrine tumors.镓- DOTATATE 正电子发射断层扫描/计算机断层扫描在神经内分泌肿瘤的诊断、治疗、随访和预后中的应用。
Future Oncol. 2018 Jan;14(2):111-122. doi: 10.2217/fon-2017-0393. Epub 2017 Oct 26.
5
Diffusion weighted magnetic resonance imaging of liver: Principles, clinical applications and recent updates.肝脏的扩散加权磁共振成像:原理、临床应用及最新进展
World J Hepatol. 2017 Sep 18;9(26):1081-1091. doi: 10.4254/wjh.v9.i26.1081.
6
Primary benign liver lesions.原发性良性肝脏病变。
Eur J Radiol. 2017 Oct;95:378-398. doi: 10.1016/j.ejrad.2017.08.028. Epub 2017 Sep 1.
7
Morphological and Functional Imaging for Detecting and Assessing the Resectability of Neuroendocrine Liver Metastases.神经内分泌肝脏转移瘤的检测和可切除性评估的形态学和功能影像学
Neuroendocrinology. 2018;106(1):74-88. doi: 10.1159/000479293. Epub 2017 Jul 21.
8
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Neoplasia: Peptide Receptor Radionuclide Therapy with Radiolabeled Somatostatin Analogues.ENETS神经内分泌肿瘤护理标准共识指南:放射性标记生长抑素类似物的肽受体放射性核素治疗
Neuroendocrinology. 2017;105(3):295-309. doi: 10.1159/000475526. Epub 2017 Apr 13.
9
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Neoplasms. Systemic Therapy 2: Chemotherapy.神经内分泌肿瘤治疗标准的ENETS共识指南。全身治疗2:化疗。
Neuroendocrinology. 2017;105(3):281-294. doi: 10.1159/000473892. Epub 2017 Apr 5.
10
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Neoplasms: Systemic Therapy - Biotherapy and Novel Targeted Agents.神经内分泌肿瘤治疗标准的ENETS共识指南:全身治疗——生物治疗与新型靶向药物
Neuroendocrinology. 2017;105(3):266-280. doi: 10.1159/000471880. Epub 2017 Mar 29.